BMS-817399 Uses, Dosage, Side Effects and more
BMS-817399 is under investigation in clinical trial NCT01404585 (Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis).
| Trade Name | BMS-817399 |
| Generic | BMS-817399 |
| Type | |
| Formula | C23H36ClN3O4 |
| Weight | Average: 454.01 Monoisotopic: 453.2394344 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
